Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth E Palmer

Showing results (21-30 of 69) with videos related to

Pageof 7
Sort By:
Antimicrobial Agents and Chemotherapy|February 14, 2013
Efficient single tobamoviral vector-based bioproduction of broadly neutralizing anti-HIV-1 monoclonal antibody VRC01 in Nicotiana benthamiana plants and utility of VRC01 in combination microbicidesKrystal Teasley Hamorsky, Tiffany W Grooms-Williams, Adam S Husk, et al.
Virology|October 4, 2006
Assembly of trans-encapsidated recombinant viral vectors engineered from Tobacco mosaic virus and Semliki Forest virus and their evaluation as immunogensMark L Smith, Tina Corbo, Jacqueline Bernales, et al.
Vaccine|November 22, 2018
Vaccine synergy with virus-like particle and immune complex platforms for delivery of human papillomavirus L2 antigenAndrew G Diamos, Dalia Larios, Lauren Brown, et al.
Antiviral Research|July 19, 2016
Middle East respiratory syndrome coronavirus infection is inhibited by griffithsinJean K Millet, Karin Séron, Rachael N Labitt, et al.
Antimicrobial Agents and Chemotherapy|September 8, 2011
Griffithsin has antiviral activity against hepatitis C virusPhilip Meuleman, Anna Albecka, Sandrine Belouzard, et al.
AIDS Research and Human Retroviruses|May 22, 2012
Combinations of griffithsin with other carbohydrate-binding agents demonstrate superior activity against HIV Type 1, HIV Type 2, and selected carbohydrate-binding agent-resistant HIV Type 1 strainsGeoffrey Férir, Dana Huskens, Kenneth E Palmer, et al.
Omics : a Journal of Integrative Biology|July 30, 2002
Epigenetic modification of plants with systemic RNA virusesWayne P Fitzmaurice, Steve Holzberg, John A Lindbo, et al.
Vaccine|July 25, 2006
TMV-peptide fusion vaccines induce cell-mediated immune responses and tumor protection in two murine modelsAlison A McCormick, Tina A Corbo, Sherri Wykoff-Clary, et al.
Antimicrobial Agents and Chemotherapy|April 2, 2020
Rapid-Release Griffithsin Fibers for Dual Prevention of HSV-2 and HIV-1 InfectionsKevin M Tyo, Amanda B Lasnik, Longyun Zhang, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|April 27, 2018
pH-responsive delivery of Griffithsin from electrospun fibersKevin M Tyo, Jinghua Duan, Pravallika Kollipara, et al.
Pageof 7

Showing results (21-30 of 69) with videos related to

Sort By:
Pageof 7
Antimicrobial Agents and Chemotherapy|February 14, 2013
Efficient single tobamoviral vector-based bioproduction of broadly neutralizing anti-HIV-1 monoclonal antibody VRC01 in Nicotiana benthamiana plants and utility of VRC01 in combination microbicidesKrystal Teasley Hamorsky, Tiffany W Grooms-Williams, Adam S Husk, et al.
Virology|October 4, 2006
Assembly of trans-encapsidated recombinant viral vectors engineered from Tobacco mosaic virus and Semliki Forest virus and their evaluation as immunogensMark L Smith, Tina Corbo, Jacqueline Bernales, et al.
Vaccine|November 22, 2018
Vaccine synergy with virus-like particle and immune complex platforms for delivery of human papillomavirus L2 antigenAndrew G Diamos, Dalia Larios, Lauren Brown, et al.
Antiviral Research|July 19, 2016
Middle East respiratory syndrome coronavirus infection is inhibited by griffithsinJean K Millet, Karin Séron, Rachael N Labitt, et al.
Antimicrobial Agents and Chemotherapy|September 8, 2011
Griffithsin has antiviral activity against hepatitis C virusPhilip Meuleman, Anna Albecka, Sandrine Belouzard, et al.
AIDS Research and Human Retroviruses|May 22, 2012
Combinations of griffithsin with other carbohydrate-binding agents demonstrate superior activity against HIV Type 1, HIV Type 2, and selected carbohydrate-binding agent-resistant HIV Type 1 strainsGeoffrey Férir, Dana Huskens, Kenneth E Palmer, et al.
Omics : a Journal of Integrative Biology|July 30, 2002
Epigenetic modification of plants with systemic RNA virusesWayne P Fitzmaurice, Steve Holzberg, John A Lindbo, et al.
Vaccine|July 25, 2006
TMV-peptide fusion vaccines induce cell-mediated immune responses and tumor protection in two murine modelsAlison A McCormick, Tina A Corbo, Sherri Wykoff-Clary, et al.
Antimicrobial Agents and Chemotherapy|April 2, 2020
Rapid-Release Griffithsin Fibers for Dual Prevention of HSV-2 and HIV-1 InfectionsKevin M Tyo, Amanda B Lasnik, Longyun Zhang, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|April 27, 2018
pH-responsive delivery of Griffithsin from electrospun fibersKevin M Tyo, Jinghua Duan, Pravallika Kollipara, et al.
Pageof 7